Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
-$53.16M-222%$43.7M+103%$21.57M+330%-$9.39M+50.2%-$18.84M-346%
$4.17M+2.7%$4.07M+0.9%$4.03M+7.9%$3.73M+8.4%$3.44M-4.7%
$3.64M-15.9%$4.32M+41.1%$3.07M+20.6%$2.54M-24.5%$3.37M+16.5%
$21.13M-$32.87M-64.9%-$19.94M-282%
$3.15M-32.4%$4.65M+108%$2.24M-38.6%$3.64M+0.3%$3.63M+7.9%
-$3.15M+32.4%-$4.65M-108%-$2.24M+38.6%-$3.64M-0.3%-$3.63M-7.9%
-$20.21M-320%-$4.81M+52.9%-$10.21M-3,444%-$288K+86.0%-$2.06M-106%
-$2.23M-$9.36M+74.6%-$36.8M-43.7%-$25.62M-162%
$17.98M-$36.51M-55.0%-$23.56M-411%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Organogenesis Holdings Inc. generate?
Organogenesis Holdings Inc. (ORGO) generated -$20.7M in operating cash flow over the trailing twelve months.
What is Organogenesis Holdings Inc.'s free cash flow?
After $13.7M of capital expenditures, Organogenesis Holdings Inc.'s free cash flow was -$34.5M over the trailing twelve months, down 67.6% year over year.
Where does Organogenesis Holdings Inc.'s cash flow data come from?
Every line is extracted from Organogenesis Holdings Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.